Pitogo, Azrielle T.
HRN: 13-42-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2022
AMOXICILLIN 250MG/5ML, 60ML SUSPENSION (BOT)
06/02/2022
06/09/2022
ORAL
3ml
TID
Vaginal Laceration Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes